Denemek ALTIN - Özgür

Wallet Half Full?

Business Standard

|

September 15, 2025

Paytm's comeback trail looks open, but regulatory shadows haven't vanished entirely

- AJINKYA KAWALE

Wallet Half Full?

On August 5, Antfin, the Chinese investment arm of Alibaba, exited Paytm completely. A week later, on August 12, Paytm Payments Services Ltd (PPSL), the payments arm of One97 Communications (OCL), secured an in-principle nod from the Reserve Bank of India (RBI) to function as an online payment aggregator (PA).

This approval marked the end of a two-year wait, during which PPSL was barred from onboarding new merchants. The delay has caused the firm to lose ground in the fast-growing online merchant space, where rivals such as Razorpay and Cashfree Payments, despite facing their own temporary embargoes, have managed to surge ahead.

"One can connect the dots. The company cleared Chinese investment from its cap table, and soon after got RBI's nod to operate as a PA," said a top industry executive, requesting anonymity.

Yet, the question remains: Is Paytm out of regulatory knot?

Crisis to compliance

In its 24th annual general meeting in September last year, the company's founder, Vijay Shekhar Sharma, called for a "compliance-first" approach into its fintech business while focusing on regulation and the core business of the firm—payments and financial services.

"The important thing for us to remember is that if we do not make compliance and risk a core part of the business, then it does not become the bigger business that we envision," Sharma said after restrictions were imposed on Paytm Payments Bank, earlier in 2024. "As far as the group and entity is concerned, we now look at [a] compliance-first, technology-second approach," he added.

The remarks hold weight, as nearly 20 months on, the RBI has yet to lift the restrictions imposed on Paytm Payments Bank in 2024 over compliance lapses.

Even if restrictions are eased, the firm faces the daunting task of redoing the know your customer (KYC) checks for its large customer base.

Business Standard'den DAHA FAZLA HİKAYE

Business Standard

FD left without a Will? Here's how children, grandchildren can claim money

Fixed deposits (FDs) are a common savings tool across Indian households.

time to read

1 min

February 14, 2026

Business Standard

Reliance gets US licence to directly buy Venezuela oil

Private-sector oil refiner Reliance Industries Limited (RIL) last week received a general licence from the United States (US) government to buy Venezuelan oil, an industry executive told Business Standard.

time to read

1 mins

February 14, 2026

Business Standard

Torrent Pharma profit rises 26%

Ahmedabad-based Torrent Pharmaceuticals on Friday posted a 26 per cent year-on-year (Y-0-Y) increase in net profit on a consolidated basis for the third quarter of the financial year (Q3FY26) to %635 crore. The revenue from operations also grew 17.6 per cent to %3,303 crore.

time to read

1 min

February 14, 2026

Business Standard

Delhi-Dhaka ties may warm up after BNP’s win

But stronger Jamaat a concern

time to read

2 mins

February 14, 2026

Business Standard

Friday the 13th caps a week of AI-sparked horror in IT stocks

Top software exporters suffer nearly ₹5 trn mcap loss as rout deepens

time to read

2 mins

February 14, 2026

Business Standard

BEE may rationalise technology credits

The Bureau of Energy Efficiency (BEE) is planning to rationalise the list of technologies that carmakers can classify as \"fuel-saving\" to claim \"technology derogation credits\" while calculating the average emission of carbon dioxide in a fleet of vehicles, Business Standard has learnt.

time to read

2 mins

February 14, 2026

Business Standard

Leverage, time & the long game

This is the game every nation is now learning to play. Some are finding new allies or seeing value among nations where they'd seen marginal interest. The starkest example is India and Europe

time to read

5 mins

February 14, 2026

Business Standard

‘Biopharma Shakti shows India focusing on being biopharma hub’

Fresh from a reduction in debt and a capital raise of $1 billion, Biocon Ltd is sharpening its focus on biosimilars, GLP-1s (glucagon-like peptide-1s), and manufacturing on a global scale. In a video interaction with Sohini Das, Biocon Group Chairperson Kiran Mazumdar-Shaw explains how lower borrowing costs will lift profitability, and why regulatory reform and adopting artificial intelligence (AI) are critical for India to be a biopharma hub. Edited excerpts:

time to read

3 mins

February 14, 2026

Business Standard

Munich Conference: German Chancellor calls for reset with US as old global order crumbles

German Chancellor Friedrich Merz on Friday called for a stronger Europe to reset its ties with the United States, wanting Washington to “repair and revive trust” in a dangerous new era of great power politics as the old global order crumbles.

time to read

1 mins

February 14, 2026

Business Standard

₹70 lakh for 10 secs: India-Pak clash sends ad rates over the ropes

Days after Pakistan backtracked on its earlier decision to boycott the marquee showdown with India at the ongoing ICC Men's T20 World Cup, the commercial upswing following that clarity is already visible.

time to read

2 mins

February 14, 2026

Listen

Translate

Share

-
+

Change font size